UBM fundamentals
ULISSE BIOMED financial statements, including revenue, expenses, and profit
The total revenue of UBM for the last semiannual is 397.07 k EUR, and it's 7.07% higher compared to the previous semiannual. The net income of H2 24 is -2.87 M EUR.
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: EUR
TTM